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Method
Introduction
In the early spring of 2017 hunters, forest 
workers, and people with frequent
recreational activities in nature were invited 
to participate in this study, supplying a blood 
sample and afterwards answering an 
electronic survey on i.e. vector exposure, 
vaccination status and whether they had 
fallen ill after a tick-,or insect bite.
Serum was tested for IgG antibodies 
against B.b.s.l. and TBEV by ELISA tests 
(Enzygnost® Lyme link VlsE/IgG and Anti-
TBE/FSME Virus (IgG, IgM) on the 
BEP2000 system, Siemens Healthcare 
A/S).
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The tick, Ixodes ricinus, is common in 
most of Denmark. It can carry several 
pathogenic microorganisms. The most 
important, from a public health 
perspective, are Borrelia burgdorferi sensu 
lato (B.b.s.l.) and Tick-borne encephalitis 
virus (TBEV), since these can cause 
infection of the nervous system and in 
some cases, result in lasting sequelae 
(1,2). The aim of this study was to 
determine the seroprevalence of these two 
pathogens in a population at risk.
CCEVI – Clinical Center of Emerging and Vectorborne Infections
Conclusion
Results
591 participants were included in the 
study, of these 340 completed the 
survey, of these 310 are men. The 
results of these 340 are presented here. 
The participants primarily consist of 
hunters. Antibody results are shown in 
table 1.
Note: Since the submission of the abstract the results have been updated to 340 participants.
Blood sampling in the local Hunter Association 
on the island Fanø.
Figure 1: Results of IgG antibodies against 
B.b.s.l., divided by age group, in 340 people 
with high risk of tick bites. 
IgG antibodies in plasma
No. (%) of 
participants 
Positiv Negativ Inconklusive
TBE 
IgG
340 (100.0) 36 
(10.59)
297 
(87,35)
7 
(2.06)
Borrelia 
IgG
340 (100.0) 73 
(21.47)
258 
(75.88)
9 
(2.65)
Table 1: Results of IgG antibodies against 
Borrelia burgdorferi and TBE in 340 people at 
risk of tick bite. 
• 21,47 % (73/340) had IgG antibodies
against B.b.s.l., 2.65 % (9/340) were
inconclusive and 75.88 % (258/340) 
negative. But only 17.8 % (13/73) 
reported iless after tickbite. 
• There are significantly more 
participants above 50 years of age 
with IgG antibodies against B.b.s.l. (P 
= 0,04), figure 1. 
Borrelia
• 13.9 % (45/324) reported illness after 
a tickbite. 16 did not answer. 42 of 
these contacted their GP and 7 were 
hospitalized of whom 3 were 
diagnosed with Lyme 
neuroborreliosis, 1 with Murine 
typhus, 1 with viral meningitis and the 
last two were never diagnosed. 
• Of these 45 only 13 had antibodies 
against B.b.s.l. and 1 had antibodies 
against TBE, 4 had antibodies 
against both TBE and B.b.s.l. This 
results in 68.8 % (31/45) reporting 
illness without detectable antibodies.
Illness after tick bite
TBE
• 10,59 % (36/340) had IgG antibodies
against TBE, 2.06 % (7/340) were
inconclusive and 87.35 % (297/340) 
negative.
• Of the 36 positve participants only one
had not been vaccinated against any
flavivirus. The same were true for 2 
with inconclusive results.
• 49 participants were vaccinated
against TBE, but only 32 (65.31 %) 
had antibodies against TBE.  
• This is the first national Danish cross-
sectional study of IgG antibodies 
against B.b.s.l. and TBEV in a 
population at increased risk of tick 
bites.
• We found a surprisingly high 
seroprevalence of B.b.s.l. increasing 
with age.
• Many reported illness after a tickbite
with no detectable antibodies and at 
the same time many had antibodies 
without recognized illness. 
• It seem the seroprevalence of TBE in 
unvaccinated participants is almost 
zero. 
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